# Open Targets Platform 21.11 has been released!

**URL:** <https://community.opentargets.org/t/open-targets-platform-21-11-has-been-released/413>\
**Category:** Releases\
**Created:** [29 November 2021 10:30 UTC](https://community.opentargets.org/t/open-targets-platform-21-11-has-been-released/413 "2021-11-29T10:30:44Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![hcornu](https://dub1.discourse-cdn.com/flex017/user_avatar/community.opentargets.org/hcornu/32/716_2.png) [@hcornu](https://community.opentargets.org/u/hcornu)\
**Post date:** [29 November 2021 10:30 UTC](https://community.opentargets.org/t/open-targets-platform-21-11-has-been-released/413/1 "2021-11-29T10:30:44Z")

</div>

We have just released the latest data update to the Open Targets Platform — 21.11.

### Key highlights for this release:

- This release integrates new evidence for target-disease associations from the Cancer Genome Interpreter
- It also features new data following the latest release of the Genetics portal (v.6)
- Finally, we have embedded a GraphQL playground with the corresponding query to fetch the data we feature in our tables.

This release integrates 10,481,189 evidence strings to build 9,927,066 target-disease associations between 18,706 diseases and 60,636 targets from the following 22 public resources:

- 1,106,942 genetic evidence from[European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 598,721 genetic evidence from[Open Targets Genetics Portal](https://genetics.opentargets.org/)
- 2,924 genetic evidence from[Gene2Phenotype](https://www.ebi.ac.uk/gene2phenotype)
- 23,383 genetic evidence from the[Genomics England PanelApp](https://bioinfo.extge.co.uk/crowdsourcing/PanelApp/)
- 1,506 genetic evidence from[ClinGen](https://search.clinicalgenome.org/kb/gene-validity/)
- 5,989 genetic evidence from Orphanet
- 172,480 genetic evidence from the[PheWAS catalog](https://phewascatalog.org/)
- 5,134 genetic evidence from[UniProt Literature](https://www.uniprot.org/)
- 9,865 somatic evidence from[European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 3,299 somatic evidence from[intOGen](https://www.intogen.org/)
- 70,853 somatic evidence from the[Cancer Gene Census](http://cancer.sanger.ac.uk/census/)
- 33,425 somatic evidence from [Uniprot](http://www.uniprot.org/)
- 552,938 drug evidence from[ChEMBL](https://www.ebi.ac.uk/chembl/)
- 226,936 expression evidence from[Expression Atlas](https://www.ebi.ac.uk/gxa/home)
- 9,963 affected pathway evidence from[Reactome](https://reactome.org/)
- 72,371 affected pathway evidence from[SLAPenrich](https://saezlab.github.io/SLAPenrich/)
- 378 affected pathway evidence from[PROGENy](https://saezlab.github.io/progeny/)
- 389 systems biology evidence from[SysBio](https://saezlab.github.io/progeny/)
- 1,299 somatic evidence from the [Cancer Genome Interpreter](https://www.cancergenomeinterpreter.org/home)
- 1,828 CRISPR-Cas9 (Cancer Cell Lines) evidence from[Behan et al. 2019](https://europepmc.org/abstract/MED/30971826)
- 1,119,314 mouse model evidence from[PhenoDigm](https://www.sanger.ac.uk/resources/databases/phenodigm)
- 6,461,252 scientific literature evidence from co-occurence mining in[Europe PMC](https://europepmc.org/)

Additionally, the Platform now allows users to explore data on 12,594 drugs.

For more details, read [the 21.11 release blog post](https://blog.opentargets.org/open-targets-platform-21-11-release/).
